GlassScriptPhysician profile
Jason A Capo
NPI 1922212125
$51,990.72
in general payments reported to CMS, 2019-2025
13 companies · $498 in 2025
The $498 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,654 · 2023: $50K · 2024: $198 · 2025: $498.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Acquisitions: $50K · Food and Beverage: $731.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Acquisitions | $49,606.20 |
| Food and Beverage | $730.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $49,635.53 | 2022-2025 | Tapestry |
| Summit Surgical Corp. | $1,335.78 | 2022 | |
| Stryker Corporation | $154.01 | 2022-2024 | Infinity Adaptis, Blueprint Patient Specific Instrumentation |
| Skeletal Dynamics INC | $145.55 | 2022 | |
| Arthrex, INC. | $143.84 | 2025 | |
| Restor3d, INC. | $121.13 | 2022 | |
| Lifenet Health | $108.50 | 2025 | Pliafx Flo, Allograft Vmis Delivery System |
| Alaska Medical Technologies, LLC | $102.02 | 2024-2025 | |
| Bone Support INC. | $98.37 | 2025 | Ceramentbone Void Filler, Cerament G |
| Depuy Synthes Sales INC. | $90.35 | 2024-2025 | Motoband, Fibulink, Unium |
| Acumed LLC | $37.27 | 2024 | Acumed |
| Ethicon US, LLC | $18.37 | 2023 | Stratafix, Dermabond Prineo |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$218,946.28 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Capo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.